Masimo Corporation (LON:0JZ2)
Market Cap | 5.91B |
Revenue (ttm) | 1.57B |
Net Income (ttm) | -334.84M |
Shares Out | n/a |
EPS (ttm) | -6.22 |
PE Ratio | n/a |
Forward PE | 26.81 |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 5 |
Average Volume | 33 |
Open | 144.00 |
Previous Close | 142.19 |
Day's Range | 144.00 - 146.96 |
52-Week Range | 108.11 - 194.61 |
Beta | 1.21 |
RSI | 46.94 |
Earnings Date | Nov 4, 2025 |
About Masimo
Masimo Corporation develops, manufactures, and markets various patient monitoring technologies, and automation and connectivity solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, methemoglobin, hemoglobin, fractional arter... [Read more]
News
How Is The Market Feeling About Masimo?
Masimo's (NYSE: MASI) short percent of float has risen 25.65% since its last report. The company recently reported that it has 4.11 million shares sold short , which is 11.07% of all regular shares t...
Masimo Corporation (MASI) Presents At Wells Fargo 20th Annual Healthcare Conference 2025 Transcript

Masimo to Present in the Wells Fargo Healthcare Conference
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced that its management will participate in the Wells Fargo Healthcare Conference on Thursday, Sept 4, 2025 at 1:30 p.m. Eastern time...

Steve Jobs Hated Being Photographed — But Called This Portrait 'The Best Picture Ever Taken Of Me'
In 2006, Scottish photographer Albert Watson was assigned to capture Apple Inc. co-founder Steve Jobs for a magazine feature. Jobs, known for disliking photo sessions, arrived punctually at 8:59 a.m. ...

Gear News of the Week: Always-Recording Smart Glasses, and Google Teases a New Nest Speaker
Plus: Masimo sues the US Customs and Border Protection over the Apple Watch's blood oxygen sensor, Insta360 has a new action camera, and BikeOn's power meter is tiny and affordable.
US Customs sued by Masimo over approval of Apple Watch imports with blood oxygen feature
Masimo Sues US Customs Over Apple Watch Import Amid Patent Dispute
Masimo Sues US Customs Over Apple Watch Import Amid Patent Dispute

Apple Restores Blood-Oxygen Tracking To Watch After Customs Ruling — Masimo Strikes Back With Lawsuit Over Patent Rights
Apple Inc. (NASDAQ: AAPL) has reintroduced the blood-oxygen monitoring feature to its Apple Watch lineup after U.S. Customs and Border Protection approved imports of the devices — a decision that med...

Masimo sues U.S Customs over approval of Apple Watch imports
Masimo told the court that it learned of the agency's August 1 decision only after Apple announced it would reintroduce blood-oxygen reading to its watches last week.

Masimo sues US Customs over approval of Apple Watch imports
Medical monitoring technology company Masimo sued U.S. Customs and Border Protection on Wednesday over a decision by the agency that allowed Apple to import Apple Watches with blood-oxygen reading tec...

Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo O3®'s delta hemoglobin parameters have received FDA clearance for cerebral and somatic applications and all patient populations.

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025
We added key positions in Masimo, Exact Sciences, Eli Lilly, Penumbra, and Edwards Lifesciences, each with strong growth drivers and market leadership. Our investment in Masimo is supported by divesti...
Masimo outlines 24–30% EPS growth for 2025 while advancing commercial strategy and tariff mitigation
Masimo Corporation (MASI) Q2 2025 Earnings Call Transcript
Masimo Corporation 2025 Q2 - Results - Earnings Call Presentation

Masimo Reports Second Quarter 2025 Results
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) today announced its financial results for the second quarter ended June 28, 2025. Second Quarter 2025 Results From Continuing Operati...
Is the Market Bullish or Bearish on Masimo?
Masimo's (NYSE: MASI) short percent of float has fallen 7.69% since its last report. The company recently reported that it has 3.03 million shares sold short , which is 8.16% of all regular shares th...

Masimo to Report Second Quarter 2025 Financial Results after Market Close on Tuesday, August 5
IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release second quarter 2025 financial results for the period ended June 28, 2025, after the market closes on Tuesday, August 5, 2025. The co...

Masimo Joins Innovators' Network at American Heart Association Center for Health Technology & Innovation
IRVINE, Calif.--(BUSINESS WIRE)-- #Masimo--Masimo has joined the American Heart Association's Innovators' Network, a health care technology consortium.

Joe Kiani is back: After being ousted from Masimo the billionaire has returned as CEO of Like Minded Labs
Also: All the news and watercooler chat from Fortune.

How Immigrant Engineer and Entrepreneur Joe Kiani Reimagined Inclusion in Tech and Medicine
As founder of Masimo and the force behind Willow Laboratories, Kiani has contributed to life-saving innovations in patient monitoring and wellness.

MASIMO CORPORATION INVESTIGATION ALERT: Johnson Fistel, PLLP Investigates Potential Breach of Fiduciary Duties by Masimo Officers and Directors
SAN DIEGO, June 27, 2025 (GLOBE NEWSWIRE) -- Leading shareholder rights law firm Johnson Fistel, PLLP announces an investigation into potential breaches of fiduciary duties by current and former direc...

How Do Investors Really Feel About Masimo?
Masimo's (NYSE: MASI) short percent of float has risen 3.19% since its last report. The company recently reported that it has 3.13 million shares sold short , which is 8.42% of all regular shares tha...
Masimo Corporation: A Much Cleaner Picture

Here's How Much You Would Have Made Owning Masimo Stock In The Last 10 Years
Masimo (NASDAQ: MASI) has outperformed the market over the past 10 years by 4.49% on an annualized basis producing an average annual return of 15.54%. Currently, Masimo has a market capitalization of...